Geron Corporation (GERNW)

-91.35% (1Y)

Market Cap	1.82B
Revenue (ttm)	29.48M
Net Income (ttm)	-201.19M
Shares Out	n/a
EPS (ttm)	-0.32
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	2,926
Open	0.1502
Previous Close	0.1502
Day's Range	0.1502 - 0.1502
52-Week Range	0.1105 - 2.0500
Beta	n/a
RSI	42.91
Earnings Date	Mar 7, 2025

About Geron

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1990
• Employees: 229
• Stock Exchange: OTCMKTS
• Ticker Symbol: GERNW